Shanghai Int Medical is based in Jiangqiao town, Jiading district, Shanghai. [Photo/jiading.gov.cn]
Shanghai Int Medical, in collaboration with the Shanghai Sci-Tech Venture Fund, recently acquired over 81 percent of Hangzhou Weiqiang Medical, giving Int Medical an expected controlling stake of over 51 percent.
Founded in 2006 and headquartered in Jiading district, Shanghai, Int Medical is a leader in medical device manufacturing, excelling in mold development, product research, and independent sterilization. It was listed on the Hong Kong Stock Exchange in 2019.
This acquisition is expected to help Int Medical overcome technological challenges and boost the development of Jiading district's biopharmaceutical industry cluster.
Established in 2016, Weiqiang Medical specializes in peripheral vascular interventional devices. The company holds over 300 patents, including more than 200 invention patents.